Singh Biotechnology
PrivateMomentum
Top 50%
of companies Caplight tracks
Company Overview
Singh Biotechnology is a biotechnology company that discovers and develops proprietary single domain antibody therapeutics for the treatment of cancers, autoimmune diseases, and ophthalmologic conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Singh Biotechnology Comparables
Compare Singh Biotechnology with similar companies based on industry and business-model similarity.
Singh Biotechnology Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors increased 1165% MoM, from 49 to 620.
- Jan 21, 2026
Monthly visitors increased 134% MoM, reaching 1K.
Singh Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Singh Biotechnology's valuation, stock price, and market status.